by Advanced Oxygen Therapy, Inc. | Sep 16, 2020 | Press Releases
AOTI Inc. announced today an eagerly anticipated expansion of its unique multi-modality Topical Wound Oxygen (TWO2) therapy product family. The addition of a new larger extremity-chamber to the company’s peripheral vascular disease (PVD) focused product line, allows...
by Advanced Oxygen Therapy, Inc. | Apr 17, 2020 | Press Releases
HELPING MAINTAIN CONTINUITY-OF-CARE DURING THE COVID-19 PANDEMIC TWO2 MULTI-MODALITY TOPICAL WOUND OXYGEN THERAPY PROVIDES PROVEN HEALING & WOUND PROTECTIVE CARE SAFELY FOR YOUR PATIENTS AT HOME N Effective wound infection management helping keep patients out...
by Advanced Oxygen Therapy, Inc. | Apr 6, 2020 | Press Releases
AOTI Inc. announced today that since the outbreak of the COVID-19 pandemic it has been focusing all its resources on supporting a growing number of wound care patients being treated at home by its unique multi-modality Topical Wound Oxygen (TWO2) therapy. TWO2 therapy...
by Advanced Oxygen Therapy, Inc. | Oct 16, 2019 | Press Releases
AOTI Inc. today announced that a state-of-the-art Randomized Controlled Trial (RCT) demonstrating the efficacy of its unique multi-modality cyclical pressure Topical Wound Oxygen (TWO2) therapy in healing and reducing recurrence of Diabetic Foot Ulcers (DFU) has been...